Keywords: Drug resistance; Multidrug-resistant tuberculosis; Treatment outcome; XDR-TB; Khyber Pakhtunkhwa;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ASPE; allele-specific primer extension; CI; confidence interval; DST; drug susceptibility testing; FQs; fluoroquinolones; INH; isoniazid; L-J; Lowenstein-Jensen; LVX; levofloxacin; MDR-TB; multidrug-resistant tuberculosis; MXF; moxifloxacin; OFX; oflo
Keywords: Tuberculosis (TB); Multi-drug resistant tuberculosis (MDR-TB); Extensively drug-resistant tuberculosis (XDR-TB); Central nervous system (CNS) TB; Tuberculoma; Bedaquiline; AFB; acid-fast bacilli; BAL; bronchoalveolar lavage; CNS; central nervous system; C
Keywords: ALG; alginate; Cm; capreomycin; CHI; chitosan; DPIs; dry powder inhalers; E; ethambutol; EC; ethyl cellulose; ECM; extracellular matrix; Eto; ethionamide; FPF; fine particle fraction; HA; hyaluronic acid; HIP/PCA; hydrophobic ion-pairing/precipitation wit
Keywords: TB; tuberculosis; HIV; human immunodeficiency virus; DPI; dry powder inhaler; AIDS; acquired immunodeficiency syndrome; WHO; world health organization; Mtb; Mycobacterium tuberculosis; AM; alveolar macrophage; PTB; pulmonary TB; EPTB; extra pulmonary TB;
Keywords: Tuberculosis; MDR-TB; XDR-TB; HIV;
Keywords: TB; tuberculosis; MTB; Mycobacterium tuberculosis; MDR-TB; multi-drug resistant tuberculosis; XDR-TB; extensively drug resistant tuberculosis; TDR-TB; totally drug resistant tuberculosis; INH; isoniazid; WHO; World Health Organization; RIF; rifampicin; PZ
Keywords: MDR-TB; XDR-TB; Imipenem; Linezolid; Effectiveness; Safety; Tolerability;
Keywords: Molecular characterization; Aminoglycosides; MDR-TB; XDR-TB;
Keywords: Anti-tuberculosis drugs; Children; XDR-TB; MDR-TB; Pediatric tuberculosis
Keywords: HIV; human immunodeficiency virus; LTBI; latent tuberculosis infection; MDR-TB; multidrug-drug resistant tuberculosis; Mtb; Mycobacterium tuberculosis; TMPK; thymidine monophosphate kinase; dTMP; thymidine 5â²-monophosphate; dTDP; thymidine 5â²-diphosph
Keywords: MDR-TB; XDR-TB; Prevention; Treatment; Therapeutic drug monitoring; Drug dosage
Keywords: Mycobacterium tuberculosis; MDR-TB; XDR-TB; Second-line drugs; Elimination; Stop TB strategy;
Keywords: Mycobacterium tuberculosis; MDR-TB; XDR-TB; Lisboa family
Keywords: Cost analysis; Monte Carlo simulation; Tuberculosis; MDR-TB; XDR-TB; Strain resistance;
Keywords: Linezolid; Tuberculosis; MDR-TB; XDR-TB; children;
Keywords: Antitubercular activity; Isoniazid derivatives; Mycobacterium tuberculosis; Resistance; QSARs; Synthesis; AE; average error; AAE; absolute average error; ASNNs; associative neural networks; BCG; Bacillus Calmette-Guérin; CCC; concordance correlation co
TB-EFI, a novel 18-Plex microbead-based method for prediction of second-line drugs and ethambutol resistance in Mycobacterium tuberculosis complex
Keywords: NAAT; XDR-TB; Second-line drug resistance; TB; Automatized analysis; Allele call;
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond
Keywords: MDR-TB; XDR-TB; Clinical management; Drug resistance; Prevention; Consilium;
Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance?
Keywords: Multidrug-resistant tuberculosis; Whole-genome sequencing; TB profiler; TGS-TB; PhyResSE; Mykrobe predictor; AMK; Amikacin; CAP; Capreomycin; CICLO; Cicloserine; DST; Drug Susceptibility Testing; EMB; Etambutol; ETH; Ethionamide; FLQ; Fluoroquinolones; IG
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB)
Keywords: Antibiotics; Multidrug-resistant tuberculosis; MDR-TB; Extensively drug-resistant tuberculosis; XDR-TB;
Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings
Keywords: MDR-TB; XDR-TB; Shorter regimen; Treatment duration; Efficacy; Impact;
RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea
Keywords: Aminoglycosides; Efflux pump; Fluoroquinolones; MDR-TB; Tuberculosis; XDR-TB;
Linezolid-induced optic neuropathy in XDR pulmonary TB: A case series
Keywords: Linezolid; Optic neuropathy; XDR-TB; Extensively drug resistant tuberculosis;
Extensively drug-resistant tuberculosis (XDR-TB) in Morocco
Keywords: Mycobacterium tuberculosis; MDR-TB; XDR-TB; GenoType MTBDRsl; Morocco;
Laboratory evaluation of the Anyplex⢠II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance
Keywords: Mycobacterium tuberculosis; MDR-Tb; XDR-Tb; Multiplex-PCR; Real-time PCR;
Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates
Keywords: MDR-TB; second-line drugs; sequence analysis; tuberculosis (TB); XDR-TB
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
Keywords: Mtb; Mycobacterium tuberculosis; TB; Tuberculosis; MDR-TB; Multidrug-resistant tuberculosis; RIF; Rifampicin; INH; Isoniazid; PZA; Pyrazinamide; ETH; Ethambutol; WHO; World Health Organization; CYP; Cytochrome P450; ADME; Absorption, distribution, metabol
First Series of Patients With XDR and Pre-XDR TB Treated With Regimens That Included Meropenen-clavulanate in Argentina
Keywords: Tuberculosis; XDR-TB; Carbapenems; Meropenem; ClavulanateTuberculosis; TB-XDR; Carbapenems; Meropenem; Clavulanato
Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium
Keywords: MDR-TB; XDR-TB; clinical management; drug resistance; prevention; ERS/WHO Consilium
The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania
Keywords: Mycobacterium tuberculosis; Nucleic acid amplification test; Drug susceptibility testing; Xpert MTB/RIF assay; DST; drug susceptibility tests; HIV; human immunodeficiency virus; LJ; Lovenstein-Jensen medium; MDR-TB; multidrug-resistant tuberculosis; MGIT;
Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis
Keywords: Meropenem; β-Lactam prodrugs; Aqueous stability; XDR-TB;
Bedaquiline - The first ATP synthase inhibitor against multi drug resistant tuberculosis
Keywords: Bedaquiline; MDR-TB; XDR-TB; ATP synthase inhibitor; Tuberculosis;
Inactivation of multidrug resistant (MDR)- and extensively drug resistant (XDR)-Mycobacterium tuberculosis by photodynamic therapy
Keywords: MDR-TB; XDR-TB; D-value; PDT
Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections
Keywords: MDR-TB; XDR-TB; TDR-TB; Thioridazine; Cure; Enhanced intracellular killing; Inhibition of efflux pumps
Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds
Keywords: Mycobacterium tuberculosis; MDR-TB; XDR-TB; 5,6-Fused heteroaromatics; Imidazo[1,2-a]pyridine;
Representations of MDR and XDR-TB in South African newspapers
Keywords: XDR-TB; MDR-TB; Tuberculosis; Policy approaches; Media framing; Content analysis
Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa
Keywords: Drug resistance; Surveillance; Evolution; MDR-TB; XDR-TB;
Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overview
Keywords: Drug resistance; Lisboa family; MDR-TB; tuberculosis; XDR-TB
Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians
Keywords: multidrug-resistant; tuberculosis; children; XDR-TB; MDR-TB; treatment
Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1
Keywords: 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives; Anti-tubercular activity; MDR-TB; XDR-TB
Current Concepts in the Management of Tuberculosis
Keywords: AFB; acid-fast bacilli; BCG; bacille Calmette-Guérin; CFP-10; culture filtrate protein 10; DOT; directly observed therapy; EMB; ethambutol; ESAT-6; early-secreted antigenic target 6; HIV; human immuno deficiency virus; IFN-γ; interferon-γ; IGRA; IFN-γ
SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB)
Keywords: SILA compounds; MDR-TB; XDR-TB; Macrophages; Efflux pumps;
Toward an Optimized Therapy for Tuberculosis? Drugs in Clinical Trials and in Preclinical Development
Keywords: Tuberculosis; Chemotherapy; Novel mechanism of action; Drug combination; Drug resistance; Drug persistence; MDR-TB; XDR-TB;
Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in the West. Europe and United States: Epidemiology, Surveillance, and Control
Keywords: MDR-TB; XDR-TB; Tuberculosis control; Europe; United States; Epidemiology; Surveillance;